Oxford BioDynamics

Oxford BioDynamics Plc is a biotechnology company focused on the discovery and development of epigenetic biomarkers for the pharmaceutical and biotechnology industries. The company's award-winning proprietary technology platform, EpiSwitch™, is designed to accelerate the drug discovery and development process and improve the success rate of treatments.Oxford BioDynamics provides an efficient means of developing new products for screening, early detection, monitoring, and prognosis of cancers, inflammatory, autoimmune, metabolic, cardiovascular, and neurodegenerative diseases, as well as other chronic conditions associated with abnormal gene expression.